期刊文献+

免疫吸附联合小剂量环磷酰胺和糖皮质激素治疗重症系统性红斑狼疮的临床疗效观察 被引量:46

Clinical Efficacy of Immune Adsorption Combined with Small Dose of Cyclophosphamide and Glucocorticoids in Treating Severe Systemic Lupus Erythematosus
在线阅读 下载PDF
导出
摘要 目的探讨免疫吸附联合小剂量环磷酰胺和糖皮质激素治疗重症系统性红斑狼疮(SLE)的临床疗效。方法选择16例重症SLE患者,应用免疫吸附联合小剂量环磷酰胺和糖皮质激素治疗,观察其治疗前后抗核抗体(ANA)、抗双链DNA抗体(ds-DNA抗体)和免疫球蛋白IgA、IgG、IgM的滴度变化,以及对补体C3、C4、血常规和肝肾功能的影响。结果免疫吸附后患者的症状和体征均明显改善,吸附治疗后ANA、ds-DNA抗体和免疫球蛋白IgG水平均显著下降(P<0.01),血清补体C3、C4和24 h尿蛋白吸附前后比较差异无统计学意义(P>0.05)。联合小剂量环磷酰胺和糖皮质激素治疗9个月,24 h尿蛋白由(3.48±3.25)g/24 h下降至(1.31±1.02)g/24 h,差异有统计学意义(P<0.01);1例患者ANA和ds-DNA抗体滴度再度升高,其余患者仍维持在较低水平。结论免疫吸附联合小剂量环磷酰胺和糖皮质激素治疗重症SLE,能在短时间内清除患者体内ANA和ds-DNA抗体,且较长时间维持较低水平,其临床疗效显著,安全性较好。 Objective To explore the clinical effects of immunoadsorption in combination with small dose of cyclophosphamide and glucocorticoids for treatment of severe systemic lupus erythematosus.Methods Sixteen cases of severe SLE patients were treated with immunoadsorption in combination with small dose of cyclophosphamide and glucocorticoids.The observation was focused on the changes of ANA and ds-DNA pre-treatment and after-treatment,titer variation of IgA,IgG and IgM antibody,the influence of the treatment on complements of C3 and C4,the routine blood test and liver ad kidney function.Results After immunoadsorption treatment,patients showed significantly clinical improvements;ANA,ds-DNA and the level of immunoglobulin IgG all had obvious decrease(P0.01);There were no differences in the complements of C3 and C4 and 24-hour urinary protein before and after immunosorbent treatment(P0.05).After the combination of small dose of cyclophosphamide and glucocorticoids for nine months,patients′ 24-hour urinary protein was significantly decreased from(3.48±3.25) g/24 h to(1.31±1.02) g/24 h.The combination treatment was significant(P0.01).The increased titer of ANA and anti-dsDNA autoantibody was found in one patient,and no adverse reaction was found in the rest patients.Conclusion Immunoadsorption in combination with small dose of cyclophosphamide and glucocorticoids for treatment of SLE can effectively clear away patients′ ANA and anti-dsDNA autoantibody and help maintain the antibody level in a low level for a long time.The combination treatment turns out remarkable clinical efficacy as well as good safety.
作者 宁军
出处 《中国全科医学》 CAS CSCD 北大核心 2012年第15期1754-1756,共3页 Chinese General Practice
关键词 红斑狼疮 系统性 免疫吸附技术 环磷酰胺 糖皮质激素 Lupus erythematosus systemic Immunosorbent techniques Cyclophosphamide Glucocorticoids
  • 相关文献

参考文献4

二级参考文献23

  • 1Vila LM,Molina MJ,Mayor AM,et al.Clinical and prognostic value of autoantibodies in puerto ricans with systemic lupus erythematosus[J].Lupus,2006,15(12):892-898.
  • 2Chan TM,Leung JK,Ho SK,et al.Mesangial cell-binding anti-DNA antibodies in patients with systemic lupus erythematosus[J].Am Soc Nephrol,2002,13(5):1219-1229.
  • 3Schenatto CB,Xavier RM,Bredemeier M,et al.Raised serum s100b protein levels in neuropsychiatric lupus[J].Ann Rheum Dis,2006,65(6):829-831.
  • 4Deshmukh US,Bagavant H,Fu SM.Role of anti-DNA antibodies in the pathogenesis of lupus nephritis[J].Autoimmun Rev,2006,5(6):414-418.
  • 5Stummvoll GH,Aringer M,Smolen JS,et al.Igg immunoadsorption reduces systemic lupus erythematosus activity and proteinuria:a long term observational study[J].Ann Rheum Dis,2005,64(7):1015-1021.
  • 6Tan EM,Cohen AS,Fries JF,et al.The 1982 revised criteria for the classification of systemic lupus erythematosus (SLE)[J].Arthritis Rheum,1982,25:1271-1277.
  • 7Hochberg MC.Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus[J].Arthritis Rheum,1997,40(9):1725.
  • 8Jaekel HP,Trabandt A,Grobe N,et al.Anti-dsDNA antibody subtypes and anti-C1q antibodies:toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis[J].Lupus,2006,15(3):335-345.
  • 9Avina-Zubieta JA,Galindo-Rodriguez G,Kwan-Yeung L,et al.Clinical evaluation of various selected ELISA kits for the detection of anti-DNA antibodies[J].Lupus,1995,4:370-374.
  • 10Spronk PE,Limburg PC,Kallenberg CG.Serological markers of disease activity in systemic lupus erythematosus[J].Lupus,1995,4:86-94.

共引文献31

同被引文献279

引证文献46

二级引证文献272

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部